Illogically, however, HIF1A displayed a weak but negative association with DDAH1 in multivariate analysis, an observation that requires further investigation, especially because targeting DDAHs has only recently been proposed as a novel antiangiogenic strategy in cancer [46]. The gene discussed is HIF1A; the disease is cancer.